Clinical Manifestations and Gene Expression in Patients with Conventional Papillary Thyroid Carcinoma Carrying the BRAFV600E Mutation and BRAF Pseudogene-Reference-Cited by-同舟云学术

Clinical Manifestations and Gene Expression in Patients with Conventional Papillary Thyroid Carcinoma Carrying the BRAFV600E Mutation and BRAF Pseudogene

Published:2016-05 Issue:5 Volume:26 Page:691-704
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Lin Jiunn-Diann¹²³,Fu Shuai-Shuai⁴,Chen Jui-Yu⁵,Lee Chen-Hsen⁵,Chau Wing-Keung⁶,Cheng Chao-Wen¹,Wang Yuan-Hung¹⁷,Lin Yuh-Feng¹⁸,Fang Wen-Fang⁹,Tang Kam-Tsun¹⁰

Affiliation:

1. Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

2. Division of Endocrinology and Metabolism, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.

3. Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine; College of Medicine, Taipei Medical University, Taipei, Taiwan.

4. Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei, Taiwan.

5. Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.

6. Division of Hematology and Oncology, Taipei Medical University Hospital, Taipei, Taiwan.

7. Department of Medical Research, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.

8. Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.

9. Department of Family Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.

10. Division of Endocrinology and Metabolism, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2015.0044

Reference47 articles.

1. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995

2. BRAF Mutation in Papillary Thyroid Carcinoma: Pathogenic Role and Clinical Implications

3. Pathogenetic mechanisms in thyroid follicular-cell neoplasia

4. BRAF T1796A Transversion Mutation in Various Thyroid Neoplasms

5. Clinical Implication of Hot SpotBRAFMutation, V599E, in Papillary Thyroid Cancers

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of MAPK, notch and Wnt signaling pathways in papillary thyroid cancer: Evidence from a systematic review and meta-analyzing microarray datasets employing bioinformatics knowledge and literature;Biochemistry and Biophysics Reports;2024-03

2. BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma;Annals of Surgical Oncology;2024-02-01

3. A novel fluorescence–electrochemiluminescence dual-mode sensing platform for high-precision BRAF gene detection;The Analyst;2024

4. Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas;Cancers;2022-06-23

5. Epigenetic modification and BRAF gene mutation in thyroid carcinoma;Cancer Cell International;2021-12